New Brain Cancer Treatment Targets Stem Cells And Tackles Tumour Growth
Brain Cancer Treatment Targets Stem Cells And Tackles Tumour Growth
The Huffington Post UK
A new experimental approach to treating a type of brain cancer has been developed by researchers.
Medulloblastoma targets cancer stem cells - critical for maintaining tumour growth - and halts their ability to proliferate by inhibiting enzymes essential for tumour progression.
The process destroys the cancer cells' ability to grow and divide, paving the way for a new type of treatment for patients with this disease.
Open Image Modal
The research team, led by Robert Wechsler-Reya Ph.D. at Sanford-Burnham Medical Research Institute, discovered that the medulloblastoma cancer cells responsible for tumour growth and progression (tumor-propagating cells—TPCs) divide more quickly than normal cells.
Correspondingly, they have higher levels of certain enzymes that regulate the cell cycle. By using small-molecule inhibitors to stop the action of these enzymes, the researchers were able to block the growth of tumour cells from mice as well as humans.
"One tumour can have many different types of cells in it, and they can grow at different rates. By targeting fast-growing TPCs with cell-cycle inhibitors, we have developed a new route to assault medulloblastoma... and have opened the window to preventing cancer recurrence," said Wechsler-Reya.
For their research, the scientists tested the effectiveness of cell-cycle inhibitors in a specific type of brain cancer called Sonic Hedgehog (SHH)-associated medulloblastoma.
These cancers have mutations in components of the SHH pathway that regulate cell growth during normal development.
The mutations cause cell signaling to go awry, triggering the creation of cancer cells that grow uncontrollably and establish tumors. SHH-associated tumors account for 25 percent of all human cases of medulloblastoma, and the SHH pathway has been implicated in other tumor types such as lung, breast, prostate, and skin cancer.
Story continues below...
Know Your Body, Spot Cancer Symptoms
A lump or swelling anywhere on your body needs checking out(01 of10)
Open Image Modal
AXA’s research found that 79% of people were able to correctly identify breast lumps as a potential indicator of cancer. But a lump or swelling in any part of the body, including the armpit, neck, abdomen, groin or chest area, is worth having checked by a doctor. (credit:Alamy)
Talk about your toilet habits(02 of10)
Open Image Modal
Diarrhoea or changes in bowel habits are most likely to be caused by a stomach bug or eating something that disagrees with you. But if you’re noticing changes that have lasted more than a few days, for example if your bowel movements are looser for three weeks or more, or you notice any blood when you’ve been to the toilet, then make an appointment to get it checked out. (credit:Alamy)
Sores and ulcers should disappear quickly – investigate them if they don’t(03 of10)
Open Image Modal
A lot of people get mouth ulcers when their immune system is low or they’re stressed. Generally they’re nothing to worry about and, as the lining of the mouth regenerates itself every couple of weeks, shouldn’t last long. But any ulcer that hasn’t healed after three weeks merits attention from your doctor or dentist. The same goes for any sore or spot that lasts for several weeks without healing – get it checked by a doctor. (credit:Alamy)
Difficult passing urine – not just an inevitable consequence of age (04 of10)
Open Image Modal
Many men find it more difficult to pass urine as they get older, needing to go more often or urgently or being unable to go when they need to. These problems are usually caused by an enlarged prostate, which is a common condition that is not in itself cause for concern. But occasionally these symptoms can be a sign of prostate cancer – either way, men experiencing these symptoms should see their GP. Similarly, while urinary tract infections are the most likely cause of women having pain or difficulty passing urine, this should pass relatively quickly. If it doesn’t, then any sudden urges to pass urine or the need to go more often should be discussed with your doctor. (credit:Alamy)
Lost weight without dieting?(05 of10)
Open Image Modal
It’s natural for most people’s weight to fluctuate over time. But if you haven’t instigated any changes in your diet or exercise regime and have obviously lost weight, then talk to your doctor. And if you’re experiencing heavy night sweats you should seek medical advice – these don’t always have a sinister cause, and can be brought about by certain infections or medications, but they’re worth checking. (credit:Alamy)
Coughing up blood needs to be checked out(06 of10)
Open Image Modal
If you’ve coughed up any blood, you should see your doctor, regardless of the amount of blood or frequency. It can be a sign of lung cancer, so needs to be checked out. (credit:Alamy)
Coughs and sore throats(07 of10)
Open Image Modal
Most of us will experience coughs or croaky voices at some point, normally when we’ve had a cold. But as with many other changes to your body, anything that hasn’t gone away after three weeks or so should be investigated. (credit:Alamy)
Educate yourself on what to look out for(08 of10)
Open Image Modal
AXA’s research found women were more likely than men to identify key cancer warning signs, including breast lumps, changes in bowel habits and irregular moles. But for both men and women, ensuring you’re aware of symptoms to keep an eye out for is important. Knowledge is power: understanding what you’re looking for means you can any changes checked out quickly. (credit:Alamy)
Know your own body(09 of10)
Open Image Modal
AXA’s research found only 6% of men and 3% of women check their bodies daily for anything unusual. But understanding what’s normal for your own body is essential if you’re to spot when anything has changed. If you do notice changes that are persisting for a long time, or causing you pain and discomfort, then see your GP. (credit:Alamy)
Don’t put off seeing the doctor!(10 of10)
Open Image Modal
A sizeable 61% of people AXA spoke to admitted they’d delayed seeing their doctor when they spotted changes that could be potential flags for cancer. But early detection of any problems can make a huge difference if any treatment is then needed. Similarly, if changes are harmless your doctor will be able to reassure you. Overall, the sooner you go to see your GP, the better. (credit:Alamy)
"Our increased understanding of SHH-associated tumors has recently led to the development of drugs that specifically inhibit the SHH pathway. Early studies in humans with these new drugs have offered some hope for patients, but many do not respond and most patients who do respond develop resistance to the drug. For this reason, it is essential to develop alternative, or additional, therapies that are more effective than current treatment options," Wechsler-Reya said.
The team's first set of experiments used a mouse model for SHH-dependent medulloblastoma. In-vitro studies of mouse tumor cells showed that cell-cycle inhibitors caused tumor cell death. In vivo, mice that were treated with the inhibitor had smaller tumors that weighed less compared to mice that were not treated, essentially halting the progression of the tumor.
The second set of experiments used human SHH-dependent medulloblastoma cells. When the researchers treated these human tumor cells with cell-cycle inhibitors, they also observed a significant reduction in tumor growth and progression.
Finally, when the scientists combined SHH inhibitors with cell-cycle inhibitors, they found that the combination worked together to produce results that were greater than either inhibitor alone.
"These results strongly support an approach to treatment that combines SHH inhibitors with cell-cycle inhibitors to treat medulloblastoma. Our hope is that the combination of these inhibitors will prevent tumor progression and drug resistance, and improve the overall effectiveness of current treatment options. We look forward to clinical studies in human medulloblastoma patients as well as other cancers that are suitable for this approach," Wechsler-Reya said.
The research findings are described in an online paper published September 25 by Cancer Research.